Patient Capital Buys Undervalued UnitedHealth Shares

Performance Overview of Patient Capital Opportunity Equity Strategy

Patient Capital Management, a value investing firm, recently released its “Patient Capital Opportunity Equity Strategy” second-quarter 2025 investor letter. The strategy achieved a total return of 15.3% net of fees during the quarter, outperforming its unmanaged benchmark, the S&P 500 Index, which returned 10.9%. According to a three-factor performance attribution model, the selection effect positively influenced the portfolio's performance, although this was partially offset by allocation and interaction effects.

The fund’s top five holdings are worth examining to understand its best investment picks in 2025. These positions reflect the firm’s strategic focus and long-term vision for growth.

UnitedHealth Group Incorporated: A Key Holding

One of the notable stocks highlighted in the investor letter is UnitedHealth Group Incorporated (NYSE: UNH). This diversified healthcare company operates through several segments, including UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Despite recent challenges, the stock has remained a significant holding for the fund.

In the short term, UnitedHealth Group Incorporated experienced a one-month return of -4.62%, with its shares losing 49.04% of their value over the last 52 weeks. As of July 17, 2025, the stock closed at $288.07 per share, with a market capitalization of $261.32 billion.

Strategic Investment in UnitedHealth Group

Patient Capital Opportunity Equity Strategy explained its decision to invest in UnitedHealth Group Incorporated during the second quarter of 2025. The firm entered a new position in the stock after it declined more than 50% from its 2025 highs, reaching multi-year lows. This drop followed a rare misstep in the company's Medicare Advantage business, where higher-than-expected costs led to margin compression, a reduction in earnings per share, and the withdrawal of forward guidance.

In response to these challenges, the company announced a leadership change, bringing back former CEO and current Chairman Stephen Hemsley. Despite the short-term uncertainty, the fund remains confident in the company's ability to improve underwriting margins. With all competitors focused on underwriting margins, future pricing is expected to be more rational and aligned with current usage trends.

Rebuilding investor confidence may take time, but the fund believes that UnitedHealth Group’s integrated platform and unique asset mix position it to remain a category leader and return to strong returns over time. Several insiders have also stepped in to buy stock, including Stephen Hemsley with a $25 million purchase and CFO John Rex with a $5 million investment. Additionally, the company has an $8.4 billion buyback authorization and a robust 10% free cash flow yield.

Position Among Hedge Funds

UnitedHealth Group Incorporated (NYSE: UNH) ranks 18th on the list of 30 Most Popular Stocks Among Hedge Funds. According to the database, 139 hedge fund portfolios held the stock at the end of the first quarter, compared to 150 in the previous quarter. While the fund acknowledges the risks and potential of UNH as an investment, it maintains a belief that some AI stocks offer greater promise for delivering higher returns within a shorter timeframe.

For investors seeking an AI stock with significant upside potential, there are options available that could provide substantial gains. Exploring these opportunities can help diversify investment strategies and potentially enhance returns.

Additional Insights and Resources

In another article, we covered UnitedHealth Group Incorporated and shared insights from Vulcan Value Partners regarding the company. For more information, investors can refer to the hedge fund investor letters Q2 2025 page, which includes additional reports from hedge funds and other leading investors.

For further reading, consider exploring the Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. These resources provide valuable insights into market trends and investment opportunities.